Evidence map›Paper›PMID 38929159›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic

Jessica R Terrill, Angelo Patrick R Bautista, Irene Tsioutsias, Miranda D Grounds, Peter G Arthur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica R TerrillSchool of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.
Angelo Patrick R BautistaSchool of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-0640-3156
Irene TsioutsiasSchool of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-7034-1295
Miranda D GroundsSchool of Human Sciences, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-4530-9402
Peter G ArthurSchool of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-1257-8200

Funding

Duchenne UK N/ASave Our Sons N/A
6 · The paper itself

Abstract

Redox modifications to the plasma protein albumin have the potential to be used as biomarkers of disease progression and treatment efficacy in pathologies associated with inflammation and oxidative stress. One such pathology is Duchenne muscular dystrophy (DMD), a fatal childhood disease characterised by severe muscle wasting. We have previously shown in the

Indexed as

albuminalbumin oxidationbiomarkersDuchenne muscular dystrophymdx miceredox modificationstaurine

Identifiers

PMID38929159
PMCPMC11201235

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.